D
Davide Tonduti
H指数:33
被引数:4,259
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
DAT-SPECT findings in POLR3A-related striatal variant: a case report and literature review
<em>POLR3A</em>相关纹状体变异型DAT-SPECT检查结果:病例报告与文献综述
Genotype-phenotype correlations of GFAP variants in type I Alexander disease subtypes
GFAP变异在I型亚历山大病亚型中的基因型-表型相关性
Altered Dopamine Metabolism and Response to Treatment with Levodopa/Carbidopa in MCT8 Deficiency
MCT8缺乏症中多巴胺代谢的改变以及对左旋多巴/卡比多巴治疗的反应
Movement Disorders
IF7.6
Critical functional domains in pediatric onset TUBB4A-related leukodystrophy: a clinical and caregiver’s perspective
儿童期发病的TUBB4A相关白质脑病的核心功能域:临床与照护者视角
Pediatric Neurology
IF2.1
Clinical Characterization of a Multicenter International Cohort of Patients With Aicardi-Goutières Syndrome Homozygous for the RNASEH2B:p.Ala177Thr Variant: Early Clinical Markers of Disease Severity
Aicardi-Goutières综合征患者(RNASEH2B基因p.Ala177Thr变异纯合子)的多中心国际队列的临床特征:疾病严重程度的早期临床标志物
Pediatric Neurology
IF2.1
COL4A1 and COL4A2-Related Disorders – Clinical Features, Diagnostic Guidelines, and Management.
COL4A1和COL4A2相关疾病——临床特征、诊断指南和管理。
Genetics in Medicine
IF6.2
Clinical and Neurodevelopmental Characteristics of Paralogous Gain-of-Function Variants at GRIA2 p.Gly792 and GRIA3 p.Gly803
GRIA2 p.Gly792和GRIA3 p.Gly803旁系同源获得功能变异的临床及神经发育特征
CLINICAL GENETICS
IF2.3
Exploring emerging JAK inhibitors in the treatment of Aicardi-Goutières syndrome
探索新兴JAK抑制剂在Aicardi-Goutières综合征治疗中的应用
Microbiota gut-brain axis: implications for pediatric-onset leukodystrophies
微生物群肠-脑轴: 对儿科发作的脑白质营养不良的影响
Role of epigenetics and alterations in RNA metabolism in leukodystrophies
表观遗传学和RNA代谢改变在脑白质营养不良中的作用

